Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05974176 · ClinicalTrials.gov registry record · NA
Considering Racial and Acculturation Stress in Addressing Trauma
A NA study of Trauma-related PTSD, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 237
- Enrollment target
- 1
- Study location
NCT05974176: Recruiting NA study of Trauma-related PTSD, sponsored by NYU Langone Health.
NCT05974176 is a NA study of Trauma-related PTSD that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 237 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05974176, a NA study of Trauma-related PTSD, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 237 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators plan to offer two evidence based interventions - Trauma Focused Cognitive Behavioral Therapy (CBT) (TF-CBT) and Trauma Systems therapy (TST) to traumatized children and their families. The investigators are looking to evaluate the effectiveness of these interventions in the context of additional stress related to racialized trauma and acculturation stress
Primary Outcome
CATS is a 15-item assessment of potentially traumatic events and of posttraumatic stress symptoms. The total score is the sum of responses and ranges from 0-60; higher scores indicates more symptoms.
Conditions Studied
Interventions
- BEHAVIORAL Trauma Focused CBT (TF-CBT)
- BEHAVIORAL Trauma Systems therapy (TST)
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
What NCT05974176 shows while recruiting
NCT05974176 is an interventional study that assigns participants to a tested intervention. The registered 237 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Trauma-related PTSD appearing as the primary indexed condition, and to 2 interventions - of which Trauma Focused CBT (TF-CBT) is the first listed.
NCT05974176 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05974176 about?
NCT05974176 is a clinical study titled "Considering Racial and Acculturation Stress in Addressing Trauma". Investigators plan to offer two evidence based interventions - Trauma Focused Cognitive Behavioral Therapy (CBT) (TF-CBT) and Trauma Systems therapy (TST) to traumatized children and their families. The investigators are looking to evaluate the effectiveness of these interventions in the context of ...
What is the current status of trial NCT05974176?
This trial is currently recruiting. It is a NA study. The enrollment target is 237 participants. The study started on 2023-07-01. Estimated completion is 2027-08-01.
What conditions does trial NCT05974176 study?
This clinical trial studies the following conditions: Trauma-related PTSD.
What interventions are being tested in trial NCT05974176?
The interventions under investigation include: Trauma Focused CBT (TF-CBT) (BEHAVIORAL), Trauma Systems therapy (TST) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05974176?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05974176 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05974176's enrollment target sits among peer trials
237 461st of 2000 higher than 1,540 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI